- Record: found
- Abstract: not found
- Article: not found
An open-label, non-randomized, multi-arm, phase II trial evaluating pembrolizumab combined with cetuximab in patients with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Results of the interim safety analysis.
Assuntina Sacco, Karen Messer, Amanda Natsuhara, Ruifeng Chen, Deborah J. Wong, Francis P. Worden, Douglas Adkins, Emily Pittman, Jing Zhang, Gregory A. Daniels, Kathryn Gold, Maechelle Espiritu, Brian J. Sutton, Ezra Cohen, AG Sacco, K MESSER, A Natsuhara, R Chen, DJ Wong, FP Worden
2018
Read this article at
ScienceOpenPublisher
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.